Free Trial

Mitsubishi UFJ Trust & Banking Corp Buys 4,791 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Intuitive Surgical logo with Medical background
Remove Ads

Mitsubishi UFJ Trust & Banking Corp raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 314,681 shares of the medical equipment provider's stock after purchasing an additional 4,791 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned about 0.09% of Intuitive Surgical worth $164,251,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Atala Financial Inc acquired a new position in Intuitive Surgical in the fourth quarter worth about $25,000. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $31,000. Finally, Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $36,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded down $18.56 on Friday, reaching $489.35. 1,145,477 shares of the company's stock traded hands, compared to its average volume of 1,522,274. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market capitalization of $174.29 billion, a P/E ratio of 76.34, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The business's 50 day moving average price is $558.29 and its two-hundred day moving average price is $532.25.

Remove Ads

Wall Street Analysts Forecast Growth

Several analysts have weighed in on ISRG shares. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Raymond James raised their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Barclays upped their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Finally, JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $611.86.

Get Our Latest Report on ISRG

Insider Activity

In other news, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. The trade was a 60.72 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 in the last 90 days. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads